Omeros | OMER - Ordinary Share Capital

Stock Price
11.51
Daily Change
-0.08 -0.69%
Monthly
2.49%
Yearly
53.98%
Q1 Forecast
11.68

Omeros reported $611K in Ordinary Share Capital for its fiscal quarter ending in December of 2023.





Ordinary Share Capital Change Date
Adma Biologics USD 236.62M 242K Dec/2024
Alnylam Pharmaceuticals USD 132.38M 585K Dec/2025
BioMarin Pharmaceutical USD 192.3M 201K Dec/2025
Cytokinetics USD 122.26M 145K Dec/2025
Gilead Sciences USD 1.24B 1000K Dec/2025
Heron Therapeutics USD 1.52M 14K Sep/2024
Immunic USD 8K 4K Jun/2024
Insmed USD 214.26M 1.67M Dec/2025
Knight Therapeutics CAD 539.32M 1.63M Sep/2024
MacroGenics USD 63.26M 62.63M Sep/2025
Omeros USD 611K 17K Dec/2023
Pacira USD 41.12M 1.85M Dec/2025
Pfizer USD 5.69B 1000K Sep/2025
Sarepta Therapeutics USD 104.96M 196K Dec/2025
United Therapeutics USD 43.64M 740K Dec/2025
Vertex Pharmaceuticals USD 254M 0 Dec/2025
Xoma USD 87K 1000 Jun/2024